EUVIMEDEUVIMED entdecken
Crossref

CD226⁺TIGIT⁺ MAIT cells exhibit an increased relative frequency and a checkpoint-enriched phenotype in Sjögren’s disease

Ziqi Xiong, Xuzheng Song, Hanxi Luo, Bohao Yang, Yiming Gao, Ayibaota Bahabayi, Xiaochen Sun, Zhonghui Zhang, Chen Liu

Clinical Rheumatology · 2026-12 · 45 (12) · 7449-7463

DOI: 10.1007/s10067-026-08491-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 27.10.2026. Verfasst von Ziqi Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Peking University People's Hospital, 11# Xizhimen South Street, Beijing, 100044, China. Hauptthemen laut MEDLINE: Mucosal-Associated Invariant T Cells, Antigens, Differentiation, T-Lymphocyte, Sjogren's Syndrome. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Development Fund of Peking University People's Hospital, Scientific Research Development Fund of Peking University People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to characterize the phenotypic profile of CD226⁺TIGIT⁺ mucosal-associated invariant T (MAIT) cells and investigate their association with Sjögren’s disease (SjD).

Methods

Peripheral blood mononuclear cells (PBMCs) from 35 newly diagnosed, treatment-naïve SjD patients and 34 age- and sex-matched healthy controls were analyzed by flow cytometry. MAIT cells were defined as CD3⁺TCRVα7.2⁺CD161^hi and stratified into CD4⁺, double-positive (DP), double-negative (DN), and CD8⁺ subsets. CD226 and TIGIT co-expression patterns were assessed across MAIT cell subsets. CD226/TIGIT-defined MAIT-cell phenotypes were further characterized for the surface expression of CD152, LAMP1, Tim-3, CD62L, and PD-1. Exploratory receiver operating characteristic (ROC) analyses were performed to assess their ability to discriminate SjD patients from healthy controls.

Results

CD226⁺TIGIT⁺ MAIT cells were preferentially enriched in DP MAIT cells and exhibited a distinct checkpoint-enriched marker-expression profile characterized by higher surface expression of CD152 and LAMP1. Exploratory analyses in small phenotyping subsets suggested differential Tim-3, CD62L, and PD-1 expression across CD226/TIGIT-defined MAIT-cell phenotypes. Compared with healthy controls, patients with SjD displayed a significantly increased relative frequency of CD226⁺TIGIT⁺ MAIT cells, particularly within the CD4⁺ and DP MAIT subsets. However, the estimated absolute count of CD226⁺TIGIT⁺ MAIT cells did not differ significantly between the two groups, whereas the estimated absolute count of total MAIT cells was reduced in SjD, indicating relative enrichment of CD226⁺TIGIT⁺ MAIT cells within a contracted peripheral MAIT-cell compartment rather than numerical expansion. Exploratory ROC analysis demonstrated moderate discrimination between SjD patients and healthy controls, with an AUC of 0.754 for total CD226⁺TIGIT⁺ MAIT cell frequency.

Conclusion

CD226⁺TIGIT⁺ MAIT cells represent a phenotypically distinct, checkpoint-enriched MAIT-cell population associated with SjD. Their increased relative frequency within a reduced peripheral MAIT-cell compartment and distinct marker-expression profile highlight a disease-associated compositional and phenotypic difference rather than numerical expansion, while further studies in larger, clinically well-characterized cohorts are required to determine their functional significance and potential clinical relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucosal-Associated Invariant T CellsAntigens, Differentiation, T-LymphocyteSjogren's SyndromeHumansFemaleMaleT Lineage-Specific Activation Antigen 1Middle AgedAdultPhenotypeReceptors, ImmunologicCase-Control StudiesFlow CytometryAged

Stichwörter der Autor:innen

CD226MAIT cellsSjögren’s diseaseTIGIT

Substanzen

T Lineage-Specific Activation Antigen 1Antigens, Differentiation, T-LymphocyteReceptors, ImmunologicTIGIT protein, human

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Peking University People's Hospital, 11# Xizhimen South Street, Beijing, 100044, China.
  • School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Department of Clinical Laboratory, Peking University People's Hospital, 11# Xizhimen South Street, Beijing, 100044, China. liuchen-best@pku.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Scientific Research Development Fund of Peking University People's Hospital
  • Scientific Research Development Fund of Peking University People’s Hospital

Zitieren

APA

Xiong, Z., Song, X., Luo, H., Yang, B., Gao, Y., Bahabayi, A., Sun, X., Zhang, Z., & Liu, C. (2026). CD226⁺TIGIT⁺ MAIT cells exhibit an increased relative frequency and a checkpoint-enriched phenotype in Sjögren’s disease. Clinical Rheumatology, 45(12), 7449-7463. https://doi.org/10.1007/s10067-026-08491-3

Vancouver

Xiong Z, Song X, Luo H, Yang B, Gao Y, Bahabayi A, et al. CD226⁺TIGIT⁺ MAIT cells exhibit an increased relative frequency and a checkpoint-enriched phenotype in Sjögren’s disease. Clinical Rheumatology. 2026;45(12):7449-7463. doi:10.1007/s10067-026-08491-3

BibTeX
@article{Xiong2026,
  author = {Xiong, Ziqi and Song, Xuzheng and Luo, Hanxi and Yang, Bohao and Gao, Yiming and Bahabayi, Ayibaota and Sun, Xiaochen and Zhang, Zhonghui and Liu, Chen},
  title = {CD226⁺TIGIT⁺ MAIT cells exhibit an increased relative frequency and a checkpoint-enriched phenotype in Sjögren’s disease},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {12},
  pages = {7449--7463},
  doi = {10.1007/s10067-026-08491-3}
}
Kostenlos starten →